Norgine backs European Colorectal Cancer campaign

Amy Schofield 06 March 2018

Norgine has announced its continued support to the European Colorectal Cancer awareness campaign throughout the month of March 2018.

As a market leader in providing bowel cleansing and colonoscopy products which aim to facilitate high quality colonoscopy, Norgine has been collaborating with key European patient organisations in order to increase the detection of colorectal cancer and to help improve patients’ quality of life.

Colonoscopy is a vital screening procedure to detect and remove adenomas and polyps that can result in colorectal cancer.

Colorectal cancer is the second most common cause of cancer-related mortality in Europe, with over 447,000 new diagnoses every year. The disease is largely preventable, with early detection being associated with a 90% cure rate.

Norgine’s bowel cleansing and colonoscopy portfolio includes KLEAN-PREP®, MOVIPREP®, ENDOCUFF VISION® and PLENVU®. 

#Time4Change #ECCAM18

Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.